Skip to main content
Log in

Intra-arterial Adriamycin chemotherapy for bladder cancer

Semiselective intra-arterial chemotherapy with compression of the femoral arteries at the time of injection

  • Intra-Arterial Adriamycin, Bladder Cancer
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

Twenty patients with bladder cancer were treated by semiselective intra-arterial chemotherapy with Adriamycin. Ten of them were given the agent while the femoral arteries were compressed, to prevent loss of the agent into the external iliac arteries. The other ten were given Adriamycin without this compression. Clinical and pathological responses of tumor and the side-effects were examined in these two groups. The results of the comparative study led us to the conclusion that the compression technique is a simple and valuable means of decreasing the side-effects of Adriamycin and increasing tumor response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Arcamone F, Casinelli G, Franceschi G et al. (1972) Structure and physiochemical properties of Adriamycin (doxorubicin). In: Carter SK, Di Marco A, Ghione M et al. (eds) International Symposium on Adriamycin. Springer, Berlin Heidelberg New York, p 9

    Google Scholar 

  2. Benjamin RS (1975) A practical approach to Adriamycin (NSC-123127) toxicity. Cancer Chemother Rep [1] 6: 191

    Google Scholar 

  3. Blum AH, Carter SK (1974) Adriamycin: A new anticancer drug with significant clinical activity. Ann Intern Med 80: 245

    Google Scholar 

  4. Bonadonna G, Monfardini S, De Lena M et al. (1970) Phase I and preliminary phase II evaluation of Adriamycin (NSC-123127). Cancer Res 30: 2572

    Google Scholar 

  5. Bonadonna G, Bereta G, Tancini G et al. (1975) Adriamycin (NSC-123127) studies at the Instituto Nazionale Tumori, Milan. Cancer Chemother Rep [3] 6: 231

    Google Scholar 

  6. Bristow MR, Billingham ME, Mason JW, Daniels JR (1978) Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep 62: 837

    Google Scholar 

  7. Carter SK (1975) Adriamycin — A review. J Natl Cancer Inst 55: 1265

    Google Scholar 

  8. Cross RJ, Glashian RE, Humphrey CS et al. (1976) Treatment of advanced bladder cancer with Adriamycin and 5-fluorouracil. Br J Urol 48: 609

    Google Scholar 

  9. De Wys WD, Begg CB (1978) Comparison of Adriamycin (adria) and 5-fluorouracil (5FU) in advanced prostatic cancer. Proc AACR/ASCO 19: 331

    Google Scholar 

  10. Donaldson SS, Glick JM, Wilbur JR (1974) Adriamycin activating a recall phenomenon after radiation therapy. Ann Intern Med 81: 407

    Google Scholar 

  11. Iguchi M, Matsuura T, Minami K, Kurita T (1979) Evaluation of superselective intra-arterial administration therapy with Adriamycin against progressive bladder cancer. In: Niijima T (ed) Proceedings of the First Conference on Treatment of Urinary Tract Tumors with Adriamycin. Kyowa Hakko Kogyo, Tokyo p 145

    Google Scholar 

  12. Kimura K, Fujita H, Sasaki Y (1972) Blood levels, tissue distribution and clinical effects of Adriamycin. In: Carter SK, Di Marco A, Ghione M et al. (eds) Proceedings of the Internation Symposium on Adriamycin. Springer, Berlin Heidelberg New York, p 124

    Google Scholar 

  13. Myers CE, McGuire WP, Liss RH et al. (1977) Adriamycin: The role of lipid peroxidation in cardiac toxicity and tumor response. Science 197: 165

    Google Scholar 

  14. Nakamura T (1969) Studies on the chemotherapy of cancer of urinary bladder. I. Clinical studies on treatment with continuous infusion of anticancer agent into the internal iliac artery. Jpn J Urol 60: 633

    Google Scholar 

  15. Nevin JE, Melnik I, Baggerly JT et al. (1974) Advanced carcinoma of bladder: Treatment using hypogastric artery infusion with 5-fluorouracil, either as a single agent or in combination with bleomycin or Adriamycin and supervoltage radiation. J Urol 112: 752

    Google Scholar 

  16. Poulakos L, Schenken LL, Hagemann RF et al. (1975) Control of local tumor growth with combined fractionated radiotherapeutic and chemotherapeutic regimens. J Natl Cancer Inst 54: 1103

    Google Scholar 

  17. Shimosato Y, Oboshi S, Baba K (1971) Histological evaluation of effects of radiotherapy and chemotherapy for carcinomas. Jpn J Clin Oncol 1: 19

    Google Scholar 

  18. Uyama T, Moriwaki S (1979) Treatment of cancers of the urinary organ by intra-arterial infusion of Adriamycin. In: Niijima T (ed) Proceedings of the First Conference on Treatment of Urinary Tract Tumors with Adriamycin. Kyowa Hakko Kogyo, Tokyo p 154

    Google Scholar 

  19. Whitemore WF (1974) Guest editorial. J Urol 112: 678

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uyama, T., Moriwaki, S., Yonezawa, M. et al. Intra-arterial Adriamycin chemotherapy for bladder cancer. Cancer Chemother. Pharmacol. 11 (Suppl 1), S59–S63 (1983). https://doi.org/10.1007/BF00256720

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00256720

Keywords

Navigation